Clinical Guidance - Clinical Recommendations - Pharmacy Benefits Management Services
Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

Pharmacy Benefits Management Services

Menu
Menu

Quick Links

Veterans Crisis Line Badge
My healthevet badge
EBenefits Badge
 

Clinical Guidance - Clinical Recommendations

Alcohol Use Disorder Pharmacotherapy (Acamprosate, Naltrexone, Disulfiram) Recommendations for Use
Alpha-blocker Combination in PTSD and BPH
Alpha Blockers (Clinically Uroselective Alfuzosin Silodosin Tamsulosin) Clinical Recommendations
Anesthesia (Topical) for Surfaces of the Nasopharynx, Oropharynx, Laryngotracheal Region and Airway, Guidance for Use
Angiotensin II Receptor Antagonists, Clinical Recommendations
Anticoagulation, Special Considerations for Women of Reproductive Age
Antipsychotic Selection Algorithm Schizophrenia June 2012
Beta-Adrenergic Blockers (Heart Failure), Clinical Recommendations
Clopidogrel and Pharmacogenomic Testing
Colchicine-Guidance for Use in the Management of Gout
Combination Therapy in Tobacco Use Cessation, Recommendations
Duloxetinefor Chronic Pain Conditions, Recommendations for Use
Dysphagia, Recommendations for Medication Assessment
Gram-Positive Recs for Use Ceftaroline, daptomycin, linezolid, quin-dalf, tedizolid, telavancin, tigecycline (revised Mar 2015)
Gram-Positive Recs for Use for Newer MRSA Agents (revised June 2015)
Guidance for Disease Modifying Therapy Selection in Multiple Sclerosis
Home Glucose Monitoring Test Strips, Dispensing Guidance
Hydroxyethyl Starch (HES) Solutions in Critically Ill or Septic Patients-Clinical Recommendations
Initial Management of Multiple Myeloma
Insomnia Management Updates and Nonpharmacological VA Resources
Interim Recommendations for Managing Dyslipidemia-Cardiovascular Risk in Veteran Patients
Iron (Intravenous) in CKD, Clinical Recommendations
Methadone, Dosing Recommendations
Methotrexate Contraindications and Risk Factors for Serious Adverse Events in Inflammatory Disorders
Mineralocorticoid Receptor Antagonists (Eplerenone, Spironolactone) in Heart Failure, Recommendations for Use (Updated per 2013 ACCF/AHA Heart Failure Guideline)
Naloxone HCL RescueKits Recommendationsfor Use
Osteoporosis Algorithms Injectable Alternatives
PDE5I BPH-LUTS Evidence & Penile Rehabilitation: Summary and Recommendations
Pentoxifyline, Formulary Considerations
Phosphate Binder (lanthanum, sevelamer, ferric citrate, sucroferric oxyhydroxide) Recommendations for Use
Rifapentine, CDC Recommendations for INH-Rifapentine DOT Regimen for latent TB
Simvastatin (Labeling Changes), Clinical Recommendations
Simvastatin 80 mg Summary Guidance for Providers (December 2011)
Simvastatin 80 mg-PBM-MAP-VPE Detailed Guidance-(December 2011)
Sodium Phosphate Sodium Biphosphate Enema, Safety Considerations Rev Sep 2016
Statin-fibrate safety report-Final
Tranexamic Acid in TKA or THA
Transgender Care, Cross-Sex Hormone Therapy (Feb 2012)
Tyrosine Kinase Inhibitor (TKI) Flow Chart for the Treatment of CML
Ulipristal acetate (ella) Recommendations for Use
Vitamins to Reduce Risk of Progression in ARMD (AREDS2 Overview)
return to top go